Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges
Journal of Functional Biomaterials · 01.09.2023 · 14 (9) · 453
DOI: 10.3390/jfb14090453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 01.09.2023. Verfasst von Elham Zarenezhad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gastrointestinal tract (GIT) environment has an intricate and complex nature, limiting drugs’ stability, oral bioavailability, and adsorption. Additionally, due to the drugs’ toxicity and side effects, renders are continuously seeking novel delivery systems. Lipid-based drug delivery vesicles have shown various loading capacities and high stability levels within the GIT. Indeed, most vesicular platforms fail to efficiently deliver drugs toward this route. Notably, the stability of vesicular constructs is different based on the different ingredients added. A low GIT stability of liposomes and niosomes and a low loading capacity of exosomes in drug delivery have been described in the literature. Bilosomes are nonionic, amphiphilic, flexible surfactant vehicles that contain bile salts for the improvement of drug and vaccine delivery. The bilosomes’ stability and plasticity in the GIT facilitate the efficient carriage of drugs (such as antimicrobial, antiparasitic, and antifungal drugs), vaccines, and bioactive compounds to treat infectious agents. Considering the intricate and harsh nature of the GIT, bilosomal formulations of oral substances have a remarkably enhanced delivery efficiency, overcoming these conditions. This review aimed to evaluate the potential of bilosomes as drug delivery platforms for antimicrobial, antiviral, antifungal, and antiparasitic GIT-associated drugs and vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran.
- Department of Medical Microbiology, Medical College, Al Muthanna University, Al Muthanna P.O. Box 07835544777, Iraq.
- College of Applied Science, University of Fallujah, Fallujah, Anbar 31002, Iraq.
- Department of Pharmacology, Faculty of Medicine, Fasa University of Medical Sciences, Fasa P.O. Box 7461686688, Iran.
- Department of Movement and Sports Sciences, Ghent University, 9000 Ghent, Belgium.
ORCID-Profile: Elham Zarenezhad, Hussein T Abdulabbas
Zitieren
APA
Zarenezhad, E., Marzi, M., Abdulabbas, H. T., Jasim, S. A., Kouhpayeh, S. A., Barbaresi, S., Ahmadi, S., & Ghasemian, A. (2023). Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges. Journal of Functional Biomaterials, 14(9), 453. https://doi.org/10.3390/jfb14090453
Vancouver
Zarenezhad E, Marzi M, Abdulabbas HT, Jasim SA, Kouhpayeh SA, Barbaresi S, et al. Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges. Journal of Functional Biomaterials. 2023;14(9):453. doi:10.3390/jfb14090453
BibTeX
@article{Zarenezhad2023,
author = {Zarenezhad, Elham and Marzi, Mahrokh and Abdulabbas, Hussein T and Jasim, Saade Abdalkareem and Kouhpayeh, Seyed Amin and Barbaresi, Silvia and Ahmadi, Shiva and Ghasemian, Abdolmajid},
title = {Bilosomes as Nanocarriers for the Drug and Vaccine Delivery against Gastrointestinal Infections: Opportunities and Challenges},
journal = {Journal of Functional Biomaterials},
year = {2023},
volume = {14},
number = {9},
pages = {453},
doi = {10.3390/jfb14090453}
}
EUVIMED